FDA Drug Application (022064) for XYZAL by UCB INC

Back to FDA Applications sponsored by UCB INC

Application Number022064
Product Number001
FormTABLET;ORAL
Dosage5MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameXYZAL
Active IngredientLEVOCETIRIZINE DIHYDROCHLORIDE

Active IngredientCount
List of drugs with Active Ingredient LEVOCETIRIZINE DIHYDROCHLORIDE2


Back to FDA Applications sponsored by UCB INC